Atlas Trials

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)

RecordFirmDate
A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006) (NCT04980872)Merck Sharp & Dohme LLC2021-11-02

Track PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS) automatically

Every clearance here is in the API, with alerts when new ones post.